August 4, 2022
CHAI works on both the supply and demand sides of the market to lower costs and increase the availability of the best health products for low- and middle-income countries. Working with the public and private sector, we help shape markets and realize savings for drugs, devices, and diagnostics in all areas of our work. We help governments maximize the impact of their limited funding by negotiating agreements with the private sector to make their health products more affordable. In parallel, we are on the ground to help countries set up treatment protocols – which medications should be used, which diagnostic tests should be done – as well as laboratory systems to do the testing, supply systems to deliver medicine and care, and training for healthcare workers. CHAI works with ministries of health to measure the impact of these programs and respond as needed – all with the goal of working ourselves out of a job. CHAI’s Global Markets and Lab Services Teams help drive our market-shaping work across programs and countries.
The Global Markets Team helps global life science companies understand what products are needed in low- and middle-income countries, what prices are sustainable, and how to navigate complex regulatory, market introduction, and procurement systems. The team helps companies that make the world’s most valuable and essential health care products find practical ways to get their products to the tens of millions of people who need them through licensing agreements, volume guarantees, and product development agreements. Together with partners, CHAI has negotiated over 120 agreements that have increased and expanded patients’ access to treatment and critical public health commodities, such as best-in-class HIV regimens and contraceptive implants.
The Global Diagnostics Team supports countries to improve laboratories and testing infrastructure and introduce and scale up new technologies, with a focus on products used to diagnose and monitor HIV, TB, and hepatitis. The team is working to address critical health care gaps, such as supporting more targeted HIV testing and the use of better quality rapid diagnostic tests, to increase diagnosis of HIV for adults and children of which only 50 percent currently know their status. Since 2006, the team has scaled up access to early infant diagnosis for millions of babies exposed to HIV and introduced point-of-care technologies that deliver same-day results, so that families do not need to wait weeks or even months before starting treatment.